✦ LIBER ✦

A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework

✍ Scribed by Sadatsafavi, Mohsen; Marra, Carlo; Marra, Fawziah; Moran, Onofre; FitzGerald, J. Mark; Lynd, Larry

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using the Incremental Net Benefit Framew

✍ Larry D. Lynd; Mehdi Najafzadeh; Lindsey Colley; Michael F. Byrne; Andrew R. Wil 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Predictors of adherence to treatment for

✍ Melbourne Hovell; Elaine Blumberg; Laura Gil-Trejo; Alicia Vera; Norma Kelley; C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB